KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$24.43
+0.33%Year over year
Reported trailing growth
- Revenue
- +60.7%
- EBITDA
- -37.4%
- EBIT
- -22.9%
- EPS
- +27.6%
- Free cash flow
- -10.5%
- Operating cash flow
- -1.6%
Forward estimates
Based on analyst estimates
- Revenue
- +43.2%
- EBITDA
- +25.2%
- EPS
- +15.4%
Three-year CAGR
- Revenue
- +131.9%
- EBITDA
- -53.1%
- EBIT
- -26.7%
- Net income
- -15.6%
- EPS
- +52.6%
- Free cash flow
- -15.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jul 1, 2026